# Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders

> **NCT06503978** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Gut-Brain-Axis Therapeutics Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Autism Spectrum Disorder
- Gastro-Intestinal Disorder
- Constipation
- Diarrhea

## Interventions

- **COMBINATION_PRODUCT:** MTP-101P
- **COMBINATION_PRODUCT:** Vancomycin
- **COMBINATION_PRODUCT:** Miralax
- **COMBINATION_PRODUCT:** Antacid
- **COMBINATION_PRODUCT:** Placebo MTP-101P
- **COMBINATION_PRODUCT:** Placebo Vancomycin

## Key facts

- **NCT ID:** NCT06503978
- **Lead sponsor:** Gut-Brain-Axis Therapeutics Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-20
- **Primary completion:** 2025-07-17
- **Final completion:** 2026-08-17
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06503978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06503978, "Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06503978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*